Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

9/11 responders show increased risk of leukemia, other cancers

Publish date:: January 14, 2020

Key clinical point: New data suggest an increased risk of leukemia among responders who worked at the World Trade Center site after the attacks on Sept. 11, 2001.

Major finding: Compared with the general population, responders had a significantly higher incidence of all cancers combined (standardized incidence ratio, 1.09). prostate cancer (SIR, 1.25), thyroid cancer (SIR, 2.19), and leukemia (SIR, 1.41).

Study details: Analysis of data on 28,729 responders enrolled in the World Trade Center Health Program General Responder Cohort.

Disclosures: This research was supported by the Centers for Disease Control and Prevention/National Institute for Occupational Safety and Health. The researchers disclosed no conflicts of interest.

Citation:

Shapiro MZ et al. JNCI Cancer Spectr. 2019 Nov 6. doi: 10.1093/jncics/pkz090.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Must Reads in ALL

In high-risk first relapse ALL, blinatumomab seen superior to consolidation chemo,

Well tolerated with promising responses in ALL/LL: Venetoclax plus navitoclax plus chemotherapy,

Highly effective in Ph-negative B-cell ALL: Hyper-CVAD with sequential blinatumomab,

Study: Complications from childhood ALL and its treatment are common, but can be managed,